Exousia Pro Inc (MAJI)
Exousia Pro Inc. is a clinical-stage biotechnology company focused on developing approaches that seek to use the therapeutic potential of exosomes in oncology applications. The company is based in Saint Petersburg, Florida, and its common stock trades on OTC Markets under the ticker MAJI. Exousia Pro was incorporated in 2010 and operated previously under the name Marijuana, Inc., before adopting its current name in April 2025.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-MAJI
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
September 17, 2026
|
—
|
—
|
—
|
274.637 K
|
—
|
—
|
—
|
—
|
—
|
—
|